SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $99,214,570 | -32.8% | 818,467 | -36.5% | 0.27% | -27.8% |
Q2 2023 | $147,638,955 | -2.4% | 1,289,198 | +17.5% | 0.37% | -14.4% |
Q1 2023 | $151,219,220 | +68.8% | 1,097,143 | +58.7% | 0.43% | +53.7% |
Q4 2022 | $89,592,389 | +2.6% | 691,406 | -12.4% | 0.28% | -5.4% |
Q3 2022 | $87,295,000 | +3697.1% | 789,712 | +2475.1% | 0.30% | +3612.5% |
Q2 2022 | $2,299,000 | -90.0% | 30,667 | -89.5% | 0.01% | -88.2% |
Q1 2022 | $22,913,000 | -68.4% | 293,299 | -63.6% | 0.07% | -56.1% |
Q4 2021 | $72,604,000 | +211.1% | 806,261 | +219.5% | 0.16% | +198.1% |
Q3 2021 | $23,340,000 | +1331.9% | 252,376 | +1103.7% | 0.05% | +1200.0% |
Q2 2021 | $1,630,000 | -74.6% | 20,967 | -75.7% | 0.00% | -76.5% |
Q1 2021 | $6,429,000 | +54.4% | 86,267 | +53.5% | 0.02% | +21.4% |
Q1 2018 | $4,164,000 | -42.3% | 56,203 | -78.6% | 0.01% | -50.0% |
Q4 2016 | $7,220,000 | +62.0% | 263,229 | +127.9% | 0.03% | +33.3% |
Q4 2015 | $4,457,000 | +55.5% | 115,518 | +29.4% | 0.02% | +40.0% |
Q3 2015 | $2,866,000 | – | 89,267 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |